
NUVB
Healthcare · Biotechnology · $1.41B market cap
$3.99-0.07 (-1.7%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -5.6% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 4, 2026 | After the close | -0.11 | -0.12 | -9.1% |
| Aug 6, 2026 | Before the open | -0.15 | -0.15 | 0.0% |
| May 4, 2026 | After the close | -0.04 | 0.01 | +123.1% |
| Mar 2, 2026 | Time not confirmed | -0.09 | -0.11 | -22.2% |
| Nov 3, 2025 | After the close | -0.17 | -0.16 | +5.9% |
| Aug 7, 2025 | Before the open | -0.17 | -0.17 | 0.0% |
| May 7, 2025 | After the close | -0.12 | -0.13 | -8.3% |
| Feb 26, 2025 | Before the open | -0.12 | -0.12 | +2.9% |
| Nov 6, 2024 | After the close | -0.10 | -0.12 | -20.0% |
| Aug 5, 2024 | Before the open | -0.05 | -1.85 | -3600.0% |
| May 14, 2024 | After the close | -0.05 | -0.04 | +20.0% |
| Feb 29, 2024 | After the close | -0.10 | -0.06 | +40.0% |
| Nov 2, 2023 | After the close | -0.08 | -0.06 |
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment…
| +25.0% |
| Aug 3, 2023 | After the close | -0.08 | -0.07 | +12.5% |
| May 4, 2023 | After the close | -0.06 | -0.08 | -33.3% |
| Mar 15, 2023 | After the close | -0.11 | -0.10 | +9.1% |
| Nov 3, 2022 | After the close | -0.15 | -0.11 | +26.7% |
| Aug 4, 2022 | After the close | -0.11 | -0.14 | -27.3% |
| May 9, 2022 | After the close | -0.13 | -0.08 | +38.5% |
| Feb 28, 2022 | After the close | -0.12 | -0.12 | 0.0% |
| Nov 10, 2021 | After the close | -0.10 | -0.09 | +10.0% |
| Aug 12, 2021 | After the close | -0.10 | -0.08 | +20.0% |
| May 17, 2021 | After the close | -0.06 | -0.11 | -83.3% |
| Mar 11, 2021 | After the close | -0.05 | -0.04 | +20.0% |
| Nov 16, 2020 | Time not confirmed | — | -0.04 | — |
| Aug 14, 2020 | Time not confirmed | — | 0.00 | — |